The pneumococcal conjugate vaccine—known as PCV—prevents around 30 percent of pneumonia, the most common cause of childhood ...

Amgen and AstraZeneca today announced positive top-line results from the Phase 3 WAYPOINT trial in patients with chronic rhinosinusitis with nasal polyps (CRSwNP [nasal polyps]). The trial ...

it’s hard to believe that AstraZeneca won't see huge benefits from being one of the first to market with a jab. Leaving aside any vaccine talk, though, it’s clear that AstraZeneca is still a ...

London’s main stock index slid to its lowest closing price for three months this afternoon amid a global sell-off. Top mining ...

LONDON, Nov 12 (Reuters) - London-listed drugmaker AstraZeneca (AZN.L), opens new tab said its plan to invest 450 million ...

AstraZeneca’s new U.S. spending also leaves in doubt the pharmaceutical company’s plans to invest in a vaccine site in ...

The company said it aims to expand its U.S. presence by the end of 2026. The new spending will be for a research-and-development center in Cambridge, Mass.; manufacturing plants in Maryland and Texas, ...

“There is well-documented economic impact on our society,” said Ostrosky. The flu vaccine benefits you by protecting you and the people you live with or spend significant time around. Everyone ...

Stories on the discovery of vital fluid-transport systems in the human body are among the winners of the 2024 AAAS Kavli Science Journalism Awards. Winning journalists also did immersive stories on ...

However, for people without functional immune systems, their benefits are unknown. A blue-ribbon government inquiry would be a robust start in filling in the blanks about mRNA vaccines’ benefits ...

Oct. 17, 2024 — With viral outbreaks spreading more quickly, faster responses and quicker development of new vaccines has become crucial. However, production of the mRNA used in vaccines is ...

AstraZeneca has become the latest big pharma company to devote new cash to its US manufacturing muscle this year as it ...